Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
2.800
+0.280 (11.11%)
At close: Dec 5, 2025, 4:00 PM EST
3.200
+0.400 (14.29%)
After-hours: Dec 5, 2025, 7:59 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.87 million as of December 5, 2025. Its market cap has increased by 30.40% in one year.
Market Cap
2.87M
Enterprise Value
-1.79M
1-Year Change
30.40%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.87M, a decrease of -95.00%. That is a compound annual growth rate of -50.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.87M | 4.32% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |